Clinical Trial Update: Neoadjuvant Chemotherapy and PD-1 Inhibitor for Locally Advanced Rectal Cancer（CONTROL-01） [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial (CONTROL-01) is evaluating neoadjuvant chemotherapy with a PD-1 inhibitor for locally advanced rectal cancer, and recruitment is ongoin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• PD-1 inhibitor (unspecified)

Snippet

Sponsor: The Affiliated Hospital of Qingdao University | Conditions: Rectal Cancer Patients | Phase 2 | Status: RECRUITING